Alrubicin 150mg Injection
Marketer
Alkem Laboratories Ltd
Salt Composition
Epirubicin (150mg)
Overview Alrubicin 150mg Injection
For treating diverse blood, breast, stomach, lung, ovarian, and soft tissue cancers, Alrubicin 150mg Injection is administered. Post-surgical bladder cancer recurrence prevention is another application. A healthcare professional administers this medication intravenously via infusion or drip, exercising extreme caution. It's used either solo or in combination chemotherapy regimens with other drugs, as determined by the physician. Dosage and frequency are individualized, depending on your condition, and may vary. Strictly adhere to your doctor's instructions; incorrect usage or overdose may cause severe adverse reactions. Benefits might not be immediately apparent (weeks or months), so don't discontinue unless directed. Alrubicin reduces contraceptive efficacy; both partners should employ reliable birth control during treatment. Common side effects include nausea, low platelet counts, alopecia, amenorrhea, fever, and skin rashes. It lowers blood cell counts, raising infection risk (potentially life-threatening). Regular blood tests, along with kidney, liver, and heart function monitoring, are essential. Prior to treatment, disclose any liver or heart conditions, and list all other medications, as interactions can impact Alrubicin's effectiveness. Notify your doctor of pregnancy or breastfeeding.
Uses of Alrubicin 150mg Injection
Malignant neoplasm
Major Benefits of Alrubicin 150mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Alrubicin 150mg Injection:
- Low blood platelets
- Nausea
- Hair loss
- Absence of menstrual periods
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Weight loss
- Decreased white blood cell count (neutrophils)
- Hot flashes
- Gastrointestinal inflammation
- Rash
- Low energy
- Eye disorder
How to use Alrubicin 150mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Alrubicin 150mg Injection works:
Alrubicin 150mg Injection is a chemotherapeutic agent used in breast cancer treatment. Its mechanism involves inhibiting topoisomerase II, a key enzyme in DNA replication within breast cancer cells. Concurrently, it generates cytotoxic free radicals, inducing DNA damage. This dual action curbs cancerous cell proliferation, ultimately leading to cell death.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Alrubicin 150mg Injection use is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Administering Alrubicin 150mg Injection during pregnancy poses a confirmed risk to the fetus. Therefore, its use is contraindicated. Nevertheless, a physician might exceptionally prescribe it in critical circumstances where the potential advantages outweigh the inherent dangers. Physician consultation is essential.
Breast feedingUNSAFE
Administration of Alrubicin 150mg Injection is contraindicated while breastfeeding due to potential infant toxicity. Evidence indicates a risk of harm to the nursing infant.
DrivingUNSAFE
Administering Alrubicin 150mg Injection might induce adverse reactions impacting driving capabilities. Nausea and vomiting, potential side effects of Alrubicin 150mg Injection, may temporarily hinder safe driving.
KidneySAFE IF PRESCRIBED
The use of Alrubicin 150mg Injection in patients with impaired kidney function appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary; however, a physician's consultation is advised. For individuals exhibiting serum creatinine exceeding 5 mg/dL, reduced dosages might be appropriate.
LiverCAUTION
Patients with liver impairment should receive Alrubicin 150mg Injection cautiously, potentially requiring dosage modification. Physician consultation is advised. Alrubicin 150mg Injection is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Alrubicin 150mg Injection :
NA
Facts to Know About Alrubicin 150mg Injection
| Label | Value |
|---|---|
| Chemical Category | Anthracycline-based drug |
| Developing Habits | No. |
| Treatment Category | Cancer Drugs |
| Action Class | Cytotoxic alkaloids |
3,018 People bought this recently